Test Method: Standard Test Method to Assess Virucidal Activity of Chemicals Intended for Disinfection of Inanimate, Nonporous Environmental Surfaces
Test Substance: Path-away aerosol solution
Active Ingredients: Citrus Extract, Ascorbic Acid, Glycerine
Surface used: Glass
Test Substance Application and Exposure Conditions: 2.0 mL of test substance was added to the dried virus inoculum and held for the contact time of 2 minutes and 5 minutes at 21°C with 53% RH.
TEST ACCEPTANCE CRITERIA
The test was considered acceptable for test substance evaluation due to the criteria below being satisfied:
The infectious virus recovered from the PRC was ≥ 4.8 Log10 TCID50 units.
Viral-induced CPE was distinguishable from test substance induced cytotoxicity (if any).
Virus was recovered from dilutions of the NE/VI control not exhibiting cytotoxicity.
The CVC did not exhibit CPE.
TEST SUBSTANCE EVALUATION CRITERIA
According to the US Environmental Protection Agency, the test substance passes the test if the following criteria are met:
The test substance must demonstrate a ≥ 3 Log10 reduction on each test carrier in the presence or absence of cytotoxicity. If cytotoxicity is present, the virus control titer should be sufficient to demonstrate a ≥ 3 Log10 reduction in viral titer on each test carrier beyond the level of cytotoxicity.
CONCLUSIONS
When tested as described, PATH-AWAY ANTI-PATHOGENIC AEROSOL SOLUTION, Lot Nos. 22020, 42020, and 52020, passed the Virucidal Hard-Surface Efficacy Test when Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) (COVID-19 Virus), containing 5.0%
FBS, was exposed to the test substance for 2 minutes and 5 minutes at 21°C and 53% RH. All controls met the criteria for a valid test. These conclusions are based on observed data.
Questions that need answering:
If the active ingredients a simple combo of the 3 things listed, what's stopping other players making it?
Do GICC / Holista have any patents / registered trademarks to protect against above?
(20min delay)